Literature DB >> 33191762

Intravenous β-blockers in STEMI: what you are about to do, do it quickly.

Borja Ibanez1,2,3.   

Abstract

Mesh：

Substances：

Year:  2020        PMID： 33191762     DOI： 10.1177/2048872620950205

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN： 2048-8726


× No keyword cloud information.
  3 in total

Review 1.  Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?

Authors:  Georgios Giannakopoulos; Stephane Noble
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

2.  Metoprolol in Critically Ill Patients With COVID-19.

Authors:  Agustín Clemente-Moragón; Juan Martínez-Milla; Eduardo Oliver; Arnoldo Santos; Javier Flandes; Iker Fernández; Lorena Rodríguez-González; Cristina Serrano Del Castillo; Ana-María Ioan; María López-Álvarez; Sandra Gómez-Talavera; Carlos Galán-Arriola; Valentín Fuster; César Pérez-Calvo; Borja Ibáñez
Journal:  J Am Coll Cardiol       Date:  2021-09-07       Impact factor: 24.094

3.  Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study.

Authors:  Raquel Díaz-Munoz; María José Valle-Caballero; Javier Sanchez-Gonzalez; Gonzalo Pizarro; Juan Carlos García-Rubira; Noemi Escalera; Valentin Fuster; Rodrigo Fernández-Jiménez; Borja Ibanez
Journal:  Basic Res Cardiol       Date:  2021-07-19       Impact factor: 17.165
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.